

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 6.97497357 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.71913442 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.71913442 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 6.65689084 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.65689084 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 6.65689084 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.65689084 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.65689084 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.65689084 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 6.34391950 |
| 11 | hydrogen peroxide biosynthetic process (GO:0050665) | 6.23466431 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.92838194 |
| 13 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.78209506 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.74528444 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.62363070 |
| 16 | reactive oxygen species biosynthetic process (GO:1903409) | 5.53639060 |
| 17 | respiratory burst (GO:0045730) | 5.46917304 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.32862917 |
| 19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 5.31488771 |
| 20 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.17881248 |
| 21 | leukocyte aggregation (GO:0070486) | 5.11898421 |
| 22 | superoxide anion generation (GO:0042554) | 5.10760371 |
| 23 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.05763076 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 5.00017668 |
| 25 | granulocyte activation (GO:0036230) | 4.93056897 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.89778356 |
| 27 | regulation of chemokine biosynthetic process (GO:0045073) | 4.86718164 |
| 28 | response to host immune response (GO:0052572) | 4.81345308 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.81345308 |
| 30 | positive regulation of heat generation (GO:0031652) | 4.64102880 |
| 31 | regulation of fever generation (GO:0031620) | 4.60511888 |
| 32 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.58127777 |
| 33 | neutrophil activation (GO:0042119) | 4.54796102 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.54289668 |
| 35 | detection of molecule of bacterial origin (GO:0032490) | 4.46872484 |
| 36 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.45974726 |
| 37 | response to interleukin-15 (GO:0070672) | 4.44037019 |
| 38 | positive regulation of mast cell degranulation (GO:0043306) | 4.42344634 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.42344634 |
| 40 | detection of other organism (GO:0098543) | 4.35944790 |
| 41 | response to host (GO:0075136) | 4.31022797 |
| 42 | response to host defenses (GO:0052200) | 4.31022797 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.31022797 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 4.22468230 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 4.19670590 |
| 46 | detection of external biotic stimulus (GO:0098581) | 4.19542292 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.16520378 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.14235588 |
| 49 | regulation of podosome assembly (GO:0071801) | 4.11591684 |
| 50 | detection of bacterium (GO:0016045) | 4.09358966 |
| 51 | cellular response to interleukin-15 (GO:0071350) | 4.08700354 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 4.07834631 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05721612 |
| 54 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.04193406 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.97880782 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.96886180 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.90664515 |
| 58 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.88525995 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.81515768 |
| 60 | microglial cell activation (GO:0001774) | 3.81204737 |
| 61 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.71591728 |
| 62 | cellular extravasation (GO:0045123) | 3.69005377 |
| 63 | neutrophil chemotaxis (GO:0030593) | 3.68640636 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.67101330 |
| 65 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.66196037 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66073412 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64600134 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.62641308 |
| 69 | cellular response to type I interferon (GO:0071357) | 3.62641308 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 3.60893870 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59703758 |
| 72 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.59687463 |
| 73 | response to type I interferon (GO:0034340) | 3.59462259 |
| 74 | neutrophil migration (GO:1990266) | 3.58668153 |
| 75 | macrophage activation (GO:0042116) | 3.56883859 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.56010681 |
| 77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.55758399 |
| 78 | regulation of heat generation (GO:0031650) | 3.55591727 |
| 79 | T-helper 1 type immune response (GO:0042088) | 3.54177424 |
| 80 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.52745665 |
| 81 | myeloid leukocyte mediated immunity (GO:0002444) | 3.48799667 |
| 82 | positive regulation of interferon-alpha production (GO:0032727) | 3.47751965 |
| 83 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45949299 |
| 84 | regulation of mast cell activation (GO:0033003) | 3.43215634 |
| 85 | negative regulation of phagocytosis (GO:0050765) | 3.39627015 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.39055644 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 3.38652190 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 3.37891749 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.37265093 |
| 90 | positive regulation of leukocyte degranulation (GO:0043302) | 3.35185594 |
| 91 | regulation of tolerance induction (GO:0002643) | 3.33327343 |
| 92 | regulation of interferon-alpha production (GO:0032647) | 3.30804601 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 3.28708538 |
| 94 | germinal center formation (GO:0002467) | 3.28626989 |
| 95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.28584948 |
| 96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.27691996 |
| 97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.26479861 |
| 98 | regulation of vitamin metabolic process (GO:0030656) | 3.22634573 |
| 99 | granulocyte chemotaxis (GO:0071621) | 3.22587773 |
| 100 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.22579424 |
| 101 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.22461370 |
| 102 | negative regulation of interleukin-17 production (GO:0032700) | 3.21969155 |
| 103 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.21369365 |
| 104 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.20859344 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.20859344 |
| 106 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.20023363 |
| 107 | dendritic cell migration (GO:0036336) | 3.19957214 |
| 108 | granulocyte migration (GO:0097530) | 3.17734047 |
| 109 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.17363977 |
| 110 | leukocyte mediated cytotoxicity (GO:0001909) | 3.17150375 |
| 111 | positive regulation of interleukin-6 production (GO:0032755) | 3.16814544 |
| 112 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.16626251 |
| 113 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16605643 |
| 114 | phagosome maturation (GO:0090382) | 3.16414365 |
| 115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16159466 |
| 116 | response to muramyl dipeptide (GO:0032495) | 3.15976297 |
| 117 | dendritic cell chemotaxis (GO:0002407) | 3.14576416 |
| 118 | positive regulation of chemokine production (GO:0032722) | 3.13309533 |
| 119 | regulation of B cell differentiation (GO:0045577) | 3.12763507 |
| 120 | B cell mediated immunity (GO:0019724) | 3.12510986 |
| 121 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.11685512 |
| 122 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.09970568 |
| 123 | eosinophil migration (GO:0072677) | 3.08327964 |
| 124 | positive regulation of acute inflammatory response (GO:0002675) | 3.07672745 |
| 125 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.07425907 |
| 126 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07180342 |
| 127 | negative regulation of type 2 immune response (GO:0002829) | 3.05526511 |
| 128 | leukocyte degranulation (GO:0043299) | 3.05096155 |
| 129 | chronic inflammatory response (GO:0002544) | 3.04854293 |
| 130 | regulation of regulated secretory pathway (GO:1903305) | 3.03842629 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02898678 |
| 132 | defense response to protozoan (GO:0042832) | 3.02867795 |
| 133 | cytokine secretion (GO:0050663) | 3.02612102 |
| 134 | negative regulation of interleukin-6 production (GO:0032715) | 3.01382081 |
| 135 | negative regulation of lipid storage (GO:0010888) | 3.00383459 |
| 136 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.00379439 |
| 137 | negative regulation of growth of symbiont in host (GO:0044130) | 2.98325452 |
| 138 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.98325452 |
| 139 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.98325452 |
| 140 | regulation of growth of symbiont in host (GO:0044126) | 2.98325452 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97545110 |
| 142 | negative regulation of innate immune response (GO:0045824) | 2.97356028 |
| 143 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.97085173 |
| 144 | negative regulation of amino acid transport (GO:0051956) | 2.97031108 |
| 145 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.96108700 |
| 146 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.96108700 |
| 147 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95944946 |
| 148 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95140138 |
| 149 | myeloid leukocyte activation (GO:0002274) | 2.95128808 |
| 150 | positive regulation of humoral immune response (GO:0002922) | 2.94198846 |
| 151 | regulation of mononuclear cell migration (GO:0071675) | 2.92540723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.19218313 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.93906853 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.63983905 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.29330296 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.93088824 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.67225708 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.62697254 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.51741055 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.51404706 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28817653 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.26667179 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.19301992 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05551114 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74733599 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63939549 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34544864 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31551901 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.25344595 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17861930 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16729343 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16174652 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00544305 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96173833 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.93808166 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92276223 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91742827 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90912830 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.85468387 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83876275 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79037936 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.75550647 |
| 32 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70606208 |
| 33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70465295 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67942954 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61813433 |
| 36 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58717847 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55991573 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55044214 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54005737 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50914940 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.49403025 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45998837 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44162997 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43853476 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43626746 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40446071 |
| 47 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37000413 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34267444 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31297727 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30593873 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.30281171 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30003712 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28784945 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27201653 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27068211 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26553823 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22323742 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21771478 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21684385 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20800197 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19653258 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18602796 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15823533 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15593328 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15483962 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14788459 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14545702 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14053717 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12858936 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11620704 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09962447 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09322252 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08499046 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08014133 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07775707 |
| 76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07663047 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06995892 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06872966 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06182087 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05596241 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05596241 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 0.99785573 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99657405 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98129397 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97551784 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95894652 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93913322 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93767539 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93663604 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92858490 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 0.92808449 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92684521 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92481390 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.92414244 |
| 95 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91136543 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88385536 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87885158 |
| 98 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87818773 |
| 99 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86593447 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85674905 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84867551 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83823403 |
| 103 | UTX_26944678_Chip-Seq_JUKART_Human | 0.83414914 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82715743 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82454862 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82318049 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82158917 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81453530 |
| 109 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80434956 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77875293 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76193553 |
| 112 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75550594 |
| 113 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74850999 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.73684871 |
| 115 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73607311 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.72944823 |
| 117 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.69659240 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66934350 |
| 119 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.66874731 |
| 120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.65621097 |
| 121 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.62816184 |
| 122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62645507 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61848815 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.60175057 |
| 125 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.58464802 |
| 126 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.57483577 |
| 127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.56578830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.64304288 |
| 2 | MP0003436_decreased_susceptibility_to | 4.45654685 |
| 3 | * MP0009785_altered_susceptibility_to | 4.18521352 |
| 4 | * MP0002419_abnormal_innate_immunity | 3.64135450 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.53705653 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.44007100 |
| 7 | MP0006082_CNS_inflammation | 3.19980582 |
| 8 | MP0003303_peritoneal_inflammation | 3.16962264 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.10903217 |
| 10 | * MP0005025_abnormal_response_to | 3.08764151 |
| 11 | MP0009278_abnormal_bone_marrow | 3.01099465 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.90112960 |
| 13 | MP0009764_decreased_sensitivity_to | 2.77183505 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.71922275 |
| 15 | MP0001533_abnormal_skeleton_physiology | 2.52708697 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.50459702 |
| 17 | MP0002723_abnormal_immune_serum | 2.37559384 |
| 18 | MP0005387_immune_system_phenotype | 2.32695114 |
| 19 | MP0001790_abnormal_immune_system | 2.32695114 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.28230456 |
| 21 | MP0001800_abnormal_humoral_immune | 2.27032077 |
| 22 | MP0003075_altered_response_to | 2.26637761 |
| 23 | MP0003195_calcinosis | 2.25434757 |
| 24 | MP0002132_abnormal_respiratory_system | 2.17766798 |
| 25 | MP0004947_skin_inflammation | 2.13275306 |
| 26 | MP0004510_myositis | 2.11237287 |
| 27 | MP0000685_abnormal_immune_system | 2.09940301 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.08277754 |
| 29 | MP0001845_abnormal_inflammatory_respons | 2.06599256 |
| 30 | * MP0001819_abnormal_immune_cell | 2.06005164 |
| 31 | * MP0002420_abnormal_adaptive_immunity | 2.04142833 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.95122688 |
| 33 | MP0000343_altered_response_to | 1.89587147 |
| 34 | MP0002405_respiratory_system_inflammati | 1.87650460 |
| 35 | MP0008469_abnormal_protein_level | 1.85342514 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.80924015 |
| 37 | MP0002006_tumorigenesis | 1.79767997 |
| 38 | MP0005671_abnormal_response_to | 1.74985086 |
| 39 | MP0000858_altered_metastatic_potential | 1.71298114 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.70773979 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.70085371 |
| 42 | MP0003866_abnormal_defecation | 1.65454815 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.64674811 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.55986197 |
| 45 | MP0003448_altered_tumor_morphology | 1.55572936 |
| 46 | MP0005166_decreased_susceptibility_to | 1.55145660 |
| 47 | MP0001853_heart_inflammation | 1.54606100 |
| 48 | MP0003186_abnormal_redox_activity | 1.54053138 |
| 49 | MP0004381_abnormal_hair_follicle | 1.47728028 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.45780478 |
| 51 | MP0005164_abnormal_response_to | 1.44076142 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.43060264 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.43060264 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.38391558 |
| 55 | MP0003828_pulmonary_edema | 1.37066034 |
| 56 | MP0008260_abnormal_autophagy | 1.36336846 |
| 57 | MP0003646_muscle_fatigue | 1.34088983 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.31788689 |
| 59 | MP0000716_abnormal_immune_system | 1.29712415 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.26235538 |
| 61 | MP0002933_joint_inflammation | 1.25602419 |
| 62 | MP0009840_abnormal_foam_cell | 1.23759485 |
| 63 | MP0005390_skeleton_phenotype | 1.17893378 |
| 64 | MP0009763_increased_sensitivity_to | 1.11627094 |
| 65 | MP0005310_abnormal_salivary_gland | 1.11389191 |
| 66 | MP0002398_abnormal_bone_marrow | 1.09022705 |
| 67 | MP0005451_abnormal_body_composition | 1.07203339 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.06158796 |
| 69 | MP0000604_amyloidosis | 1.02247816 |
| 70 | MP0002429_abnormal_blood_cell | 1.00657335 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.00437807 |
| 72 | MP0004883_abnormal_blood_vessel | 0.99384400 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.97688973 |
| 74 | MP0005083_abnormal_biliary_tract | 0.95744799 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.95209506 |
| 76 | MP0000689_abnormal_spleen_morphology | 0.93005099 |
| 77 | MP0001851_eye_inflammation | 0.90492981 |
| 78 | MP0008004_abnormal_stomach_pH | 0.89446301 |
| 79 | MP0000569_abnormal_digit_pigmentation | 0.86033125 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.85915368 |
| 81 | MP0001958_emphysema | 0.84953615 |
| 82 | MP0003690_abnormal_glial_cell | 0.84112903 |
| 83 | MP0003045_fibrosis | 0.82702194 |
| 84 | MP0001663_abnormal_digestive_system | 0.82358780 |
| 85 | MP0002722_abnormal_immune_system | 0.81409256 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.80637978 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.78637695 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.77754111 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.76405064 |
| 90 | MP0000490_abnormal_crypts_of | 0.76062390 |
| 91 | MP0005535_abnormal_body_temperature | 0.74737605 |
| 92 | MP0000249_abnormal_blood_vessel | 0.74501107 |
| 93 | MP0004858_abnormal_nervous_system | 0.72465548 |
| 94 | MP0000920_abnormal_myelination | 0.68978065 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.68016526 |
| 96 | MP0003878_abnormal_ear_physiology | 0.67797009 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 0.67797009 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67596496 |
| 99 | MP0001873_stomach_inflammation | 0.67454825 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.66588885 |
| 101 | MP0008874_decreased_physiological_sensi | 0.65846516 |
| 102 | MP0003795_abnormal_bone_structure | 0.64101891 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.63503439 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.62974451 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62500797 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.62486383 |
| 107 | MP0008873_increased_physiological_sensi | 0.60639899 |
| 108 | MP0000371_diluted_coat_color | 0.60435807 |
| 109 | MP0002928_abnormal_bile_duct | 0.60376859 |
| 110 | MP0005248_abnormal_Harderian_gland | 0.59053149 |
| 111 | MP0002254_reproductive_system_inflammat | 0.58248704 |
| 112 | MP0002133_abnormal_respiratory_system | 0.57849202 |
| 113 | MP0005388_respiratory_system_phenotype | 0.57849202 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.57190538 |
| 115 | MP0005165_increased_susceptibility_to | 0.56480820 |
| 116 | MP0002166_altered_tumor_susceptibility | 0.51939484 |
| 117 | MP0002139_abnormal_hepatobiliary_system | 0.51931054 |
| 118 | MP0000609_abnormal_liver_physiology | 0.48558871 |
| 119 | MP0005023_abnormal_wound_healing | 0.46921322 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.46115204 |
| 121 | MP0004130_abnormal_muscle_cell | 0.45343735 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.44451970 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.43308863 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.42185002 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.42128511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 9.76963258 |
| 2 | Eczematoid dermatitis (HP:0000976) | 9.02570930 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 8.70122900 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 8.61828240 |
| 5 | Stomatitis (HP:0010280) | 6.42781418 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 6.24512183 |
| 7 | Abnormality of macrophages (HP:0004311) | 6.14419288 |
| 8 | Gingivitis (HP:0000230) | 5.66430827 |
| 9 | Obstructive lung disease (HP:0006536) | 4.98014195 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.98014195 |
| 11 | Recurrent skin infections (HP:0001581) | 4.81668397 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 4.80146472 |
| 13 | Hypochromic microcytic anemia (HP:0004840) | 4.44998094 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.10961609 |
| 15 | Axonal loss (HP:0003447) | 4.05040347 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04758984 |
| 17 | Urticaria (HP:0001025) | 3.96771963 |
| 18 | Encephalitis (HP:0002383) | 3.94775173 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.85383034 |
| 20 | Periodontitis (HP:0000704) | 3.84686539 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.81941339 |
| 22 | Orchitis (HP:0100796) | 3.81764327 |
| 23 | Increased IgE level (HP:0003212) | 3.74112387 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.70222865 |
| 25 | Hypochromic anemia (HP:0001931) | 3.69042129 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.68191428 |
| 27 | Myositis (HP:0100614) | 3.61892615 |
| 28 | Optic neuritis (HP:0100653) | 3.60773610 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.60773610 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.57245082 |
| 31 | Cellulitis (HP:0100658) | 3.57184960 |
| 32 | Pustule (HP:0200039) | 3.56376869 |
| 33 | Thick nail (HP:0001805) | 3.54972728 |
| 34 | Episodic fever (HP:0001954) | 3.46738660 |
| 35 | Increased IgM level (HP:0003496) | 3.38646817 |
| 36 | Chest pain (HP:0100749) | 3.37382448 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 3.35201907 |
| 38 | Prolonged bleeding time (HP:0003010) | 3.31476040 |
| 39 | Vasculitis (HP:0002633) | 3.21415225 |
| 40 | Meningitis (HP:0001287) | 2.94199536 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.92293954 |
| 42 | Recurrent viral infections (HP:0004429) | 2.89126967 |
| 43 | T lymphocytopenia (HP:0005403) | 2.87307197 |
| 44 | Recurrent pneumonia (HP:0006532) | 2.84079386 |
| 45 | Disinhibition (HP:0000734) | 2.68500819 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67797829 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.67509319 |
| 48 | Osteomyelitis (HP:0002754) | 2.66622554 |
| 49 | Premature loss of primary teeth (HP:0006323) | 2.66186547 |
| 50 | Nausea (HP:0002018) | 2.64086590 |
| 51 | Microcytic anemia (HP:0001935) | 2.63533774 |
| 52 | Gingival bleeding (HP:0000225) | 2.61127598 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.60369260 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.57996409 |
| 55 | Tetraparesis (HP:0002273) | 2.57181779 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.54295666 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.54033495 |
| 58 | Abnormality of T cells (HP:0002843) | 2.52431237 |
| 59 | Glomerulonephritis (HP:0000099) | 2.51244735 |
| 60 | Gangrene (HP:0100758) | 2.48689267 |
| 61 | Granulocytopenia (HP:0001913) | 2.43731686 |
| 62 | Abnormality of the peritoneum (HP:0002585) | 2.42875833 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.41881305 |
| 64 | Joint hemorrhage (HP:0005261) | 2.40956652 |
| 65 | Leukocytosis (HP:0001974) | 2.39848016 |
| 66 | Purpura (HP:0000979) | 2.39470208 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.37349912 |
| 68 | Prostate neoplasm (HP:0100787) | 2.34443276 |
| 69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.33237092 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.32781359 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30833023 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.30833023 |
| 73 | Joint swelling (HP:0001386) | 2.30595543 |
| 74 | Agnosia (HP:0010524) | 2.27655736 |
| 75 | Lymphopenia (HP:0001888) | 2.26300987 |
| 76 | Abnormality of the endocardium (HP:0004306) | 2.25051928 |
| 77 | Sepsis (HP:0100806) | 2.22802085 |
| 78 | Abnormality of T cell physiology (HP:0011840) | 2.20183994 |
| 79 | Hematochezia (HP:0002573) | 2.19552494 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 2.17673223 |
| 81 | Glomerulopathy (HP:0100820) | 2.17590077 |
| 82 | Poor head control (HP:0002421) | 2.15386833 |
| 83 | Keratitis (HP:0000491) | 2.14214509 |
| 84 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13737468 |
| 85 | Acne (HP:0001061) | 2.11973874 |
| 86 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11466577 |
| 87 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11466577 |
| 88 | Peritonitis (HP:0002586) | 2.10992874 |
| 89 | Chronic otitis media (HP:0000389) | 2.10585335 |
| 90 | Vertigo (HP:0002321) | 2.09171175 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.08114124 |
| 92 | Petechiae (HP:0000967) | 2.07467548 |
| 93 | Arterial thrombosis (HP:0004420) | 2.04955223 |
| 94 | IgM deficiency (HP:0002850) | 2.04335852 |
| 95 | Acute hepatic failure (HP:0006554) | 2.04014639 |
| 96 | Myocardial infarction (HP:0001658) | 2.03929351 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.02449492 |
| 98 | Metaphyseal cupping (HP:0003021) | 2.00843883 |
| 99 | Bone pain (HP:0002653) | 1.99684435 |
| 100 | Nephritis (HP:0000123) | 1.97093971 |
| 101 | Hemoptysis (HP:0002105) | 1.96516386 |
| 102 | Keratoconjunctivitis (HP:0001096) | 1.96112666 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 1.95242431 |
| 104 | Slow saccadic eye movements (HP:0000514) | 1.94823772 |
| 105 | Toxemia of pregnancy (HP:0100603) | 1.94314176 |
| 106 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94123082 |
| 107 | Dysostosis multiplex (HP:0000943) | 1.93636906 |
| 108 | Increased serum ferritin (HP:0003281) | 1.88998822 |
| 109 | Loss of speech (HP:0002371) | 1.88785897 |
| 110 | Difficulty running (HP:0009046) | 1.88668029 |
| 111 | Epistaxis (HP:0000421) | 1.87072479 |
| 112 | Skin ulcer (HP:0200042) | 1.86444222 |
| 113 | Arthralgia (HP:0002829) | 1.86239770 |
| 114 | Polycythemia (HP:0001901) | 1.85971489 |
| 115 | Abnormality of the pericardium (HP:0001697) | 1.85658643 |
| 116 | Cheilitis (HP:0100825) | 1.85580471 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85519659 |
| 118 | Subacute progressive viral hepatitis (HP:0006572) | 1.85148116 |
| 119 | Amyloidosis (HP:0011034) | 1.84742116 |
| 120 | Polyneuropathy (HP:0001271) | 1.84427414 |
| 121 | Abnormality of T cell number (HP:0011839) | 1.83853059 |
| 122 | Viral hepatitis (HP:0006562) | 1.83495220 |
| 123 | Skin rash (HP:0000988) | 1.81821844 |
| 124 | Recurrent sinusitis (HP:0011108) | 1.80024353 |
| 125 | Neoplasm of head and neck (HP:0012288) | 1.79469081 |
| 126 | Esophageal neoplasm (HP:0100751) | 1.79469081 |
| 127 | Colitis (HP:0002583) | 1.78653605 |
| 128 | Progressive visual loss (HP:0000529) | 1.77920053 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.77861601 |
| 130 | Upper motor neuron abnormality (HP:0002127) | 1.75499938 |
| 131 | Peripheral demyelination (HP:0011096) | 1.74496848 |
| 132 | Abnormality of the pleura (HP:0002103) | 1.71557290 |
| 133 | Pulmonary embolism (HP:0002204) | 1.70842868 |
| 134 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.69625375 |
| 135 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69625375 |
| 136 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69625375 |
| 137 | Parakeratosis (HP:0001036) | 1.68955701 |
| 138 | Hypermelanotic macule (HP:0001034) | 1.67618800 |
| 139 | Eosinophilia (HP:0001880) | 1.66789483 |
| 140 | Anorexia (HP:0002039) | 1.66660449 |
| 141 | Abnormality of the common coagulation pathway (HP:0010990) | 1.66084799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.38912996 |
| 2 | BLK | 4.93438714 |
| 3 | MAP3K14 | 4.13291506 |
| 4 | IRAK4 | 3.35440799 |
| 5 | IRAK3 | 3.21567874 |
| 6 | PBK | 2.86344532 |
| 7 | TXK | 2.74325075 |
| 8 | TBK1 | 2.72513093 |
| 9 | FGR | 2.62029213 |
| 10 | TNK2 | 2.57970541 |
| 11 | CSK | 2.56034509 |
| 12 | MAP4K1 | 2.48165673 |
| 13 | TYK2 | 2.26184430 |
| 14 | IKBKE | 2.21079174 |
| 15 | ERN1 | 2.13479638 |
| 16 | TAOK1 | 2.04100960 |
| 17 | JAK3 | 2.01849362 |
| 18 | RIPK1 | 1.96126799 |
| 19 | IKBKB | 1.83022711 |
| 20 | PRPF4B | 1.78465287 |
| 21 | EPHB1 | 1.58088967 |
| 22 | SIK3 | 1.45481489 |
| 23 | HCK | 1.42482450 |
| 24 | STK10 | 1.41754936 |
| 25 | JAK1 | 1.38855585 |
| 26 | MAP3K13 | 1.36246929 |
| 27 | BMPR2 | 1.36096381 |
| 28 | LYN | 1.34268583 |
| 29 | CLK1 | 1.32102713 |
| 30 | ZAP70 | 1.32054271 |
| 31 | BTK | 1.25075110 |
| 32 | SYK | 1.21163408 |
| 33 | YES1 | 1.14856191 |
| 34 | TEC | 1.11934520 |
| 35 | PTK6 | 1.10028078 |
| 36 | FES | 1.09239719 |
| 37 | MAP3K12 | 1.07518429 |
| 38 | MARK2 | 1.06709643 |
| 39 | MATK | 1.06517703 |
| 40 | CSF1R | 1.06497802 |
| 41 | PRKCD | 1.05717050 |
| 42 | KIT | 1.05196590 |
| 43 | PRKD2 | 1.04216529 |
| 44 | CDK19 | 1.02864574 |
| 45 | MARK3 | 0.99282320 |
| 46 | MST1R | 0.98545503 |
| 47 | MAP3K6 | 0.98230202 |
| 48 | JAK2 | 0.97504829 |
| 49 | LCK | 0.95854187 |
| 50 | ABL2 | 0.93992650 |
| 51 | CHUK | 0.92288559 |
| 52 | SIK2 | 0.90364106 |
| 53 | ERBB3 | 0.90012484 |
| 54 | EIF2AK2 | 0.89200596 |
| 55 | RPS6KA4 | 0.86085963 |
| 56 | MST4 | 0.83668462 |
| 57 | MAP3K2 | 0.83322277 |
| 58 | MAP2K4 | 0.83016604 |
| 59 | TAOK2 | 0.82014974 |
| 60 | KSR2 | 0.80475189 |
| 61 | BMPR1B | 0.79357518 |
| 62 | TRIB3 | 0.78755053 |
| 63 | EGFR | 0.78585356 |
| 64 | TESK2 | 0.76639555 |
| 65 | BMX | 0.73229895 |
| 66 | ERBB4 | 0.72600084 |
| 67 | SMG1 | 0.72338827 |
| 68 | PTK2B | 0.71789888 |
| 69 | PRKG2 | 0.70892882 |
| 70 | MAP3K7 | 0.70641511 |
| 71 | GRK7 | 0.70459566 |
| 72 | LRRK2 | 0.70066744 |
| 73 | FGFR4 | 0.68449481 |
| 74 | STK11 | 0.68191035 |
| 75 | MAP2K3 | 0.67882064 |
| 76 | DYRK1B | 0.66303657 |
| 77 | TRPM7 | 0.65375517 |
| 78 | FYN | 0.64456181 |
| 79 | PIM2 | 0.62103246 |
| 80 | ABL1 | 0.61208809 |
| 81 | DAPK2 | 0.59232733 |
| 82 | STK38 | 0.59210445 |
| 83 | MAPK12 | 0.57628996 |
| 84 | PIM1 | 0.55202828 |
| 85 | TGFBR2 | 0.54713333 |
| 86 | IRAK1 | 0.54437861 |
| 87 | IRAK2 | 0.54424737 |
| 88 | RAF1 | 0.54298340 |
| 89 | SGK3 | 0.52734041 |
| 90 | KSR1 | 0.52698645 |
| 91 | CDC42BPA | 0.51846564 |
| 92 | PDPK1 | 0.49935034 |
| 93 | RET | 0.49000224 |
| 94 | ALK | 0.48628093 |
| 95 | MAP2K6 | 0.48189939 |
| 96 | HIPK2 | 0.47306954 |
| 97 | SIK1 | 0.46949152 |
| 98 | MAPK7 | 0.45892824 |
| 99 | ITK | 0.45771512 |
| 100 | ARAF | 0.45596058 |
| 101 | PIK3CG | 0.44906990 |
| 102 | NLK | 0.44861137 |
| 103 | PDK1 | 0.42558166 |
| 104 | ACVR1B | 0.40640931 |
| 105 | PRKCZ | 0.40589486 |
| 106 | FGFR3 | 0.38812425 |
| 107 | STK4 | 0.38350027 |
| 108 | MAP3K1 | 0.37710594 |
| 109 | IGF1R | 0.37005719 |
| 110 | KDR | 0.36931310 |
| 111 | MAP3K5 | 0.36431258 |
| 112 | DYRK3 | 0.35049948 |
| 113 | TAOK3 | 0.34250173 |
| 114 | TTN | 0.34223434 |
| 115 | PRKCQ | 0.34186809 |
| 116 | MOS | 0.33716171 |
| 117 | GRK6 | 0.33491425 |
| 118 | INSR | 0.33369148 |
| 119 | PRKCH | 0.33187748 |
| 120 | SGK2 | 0.32975402 |
| 121 | CAMK1D | 0.32767584 |
| 122 | GRK5 | 0.31333524 |
| 123 | PKN1 | 0.31192931 |
| 124 | DAPK3 | 0.30406612 |
| 125 | CAMKK1 | 0.29901737 |
| 126 | MAP3K11 | 0.29728017 |
| 127 | MAP3K3 | 0.29453813 |
| 128 | EPHA3 | 0.29383491 |
| 129 | RPS6KA6 | 0.25594209 |
| 130 | DMPK | 0.25064590 |
| 131 | CDK4 | 0.22797485 |
| 132 | MAPKAPK2 | 0.22044811 |
| 133 | NME2 | 0.21576476 |
| 134 | MAPK4 | 0.20889382 |
| 135 | RPS6KL1 | 0.20713977 |
| 136 | RPS6KC1 | 0.20713977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.28678156 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.84529791 |
| 3 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.70849462 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 3.42120884 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.80078411 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.78524232 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.76175201 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.71371102 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.60687847 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.60337266 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.48018641 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45552000 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.37957622 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.34289354 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.33808086 |
| 16 | Salmonella infection_Homo sapiens_hsa05132 | 2.31992715 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28301652 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.25802721 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23260940 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.97547275 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.88907581 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85985813 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83044551 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.61208105 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50598723 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.44301857 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37476038 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.36237438 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32002277 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.28268195 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27113959 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22129644 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21084751 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19893977 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19179004 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16917430 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15374143 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07044964 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.05812845 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.03907374 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01325412 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00127153 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98112508 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92622227 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90598593 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.89669605 |
| 47 | Endocytosis_Homo sapiens_hsa04144 | 0.89383473 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86542274 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85406248 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84402263 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84286690 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80315787 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79613134 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.79265852 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.73866807 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73209479 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71974507 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71429865 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65835232 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64262001 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63630960 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63214472 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62057537 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61844209 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59466107 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58558021 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.57845693 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57598785 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56159219 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53677635 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52879488 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50927849 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50699043 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50101451 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48494977 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48436783 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.48291831 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47401646 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46748547 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46485047 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46430412 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45886400 |
| 83 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44794447 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44780230 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44692281 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44080922 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43652103 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43344531 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42520937 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42410249 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41417722 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40683939 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37816720 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35043397 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34061258 |
| 96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29252074 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.28456998 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26592396 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25646113 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25304082 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23459864 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23281161 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22147384 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21841952 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20486548 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20405847 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20311742 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18660134 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18534969 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17491952 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15312017 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14271280 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.14126354 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.12152007 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.11524863 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11523438 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.10482530 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.10062486 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09900916 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.09795180 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07896051 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07798089 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07283870 |
| 124 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.06322218 |

